Early in the pandemic, a number of retrospective analyses compared IL-6 levels between patients with COVID-19 ARDS (acute respiratory distress syndrome) compared with non-COVID-19 ARDS or non-COVID-19 sepsis. This evidence concerns the gene IL6 and acute respiratory distress syndrome.